26
Jan
On January 17, 2022, the oral antiviral Paxlovid was approved by Health Canada. Ontario has received limited quantities from... read more
Pfizer-BioNTech COVID vaccine less effective against infection for kids 5 to 11, study suggests The vaccine’s efficacy against infection among... read more
Booster doses for youth aged 12 to 17 Effective immediately, youth aged 12 to 17 can receive their third (booster)... read more
April 2014 – New Immunization App This new innovative mobile app was created through the collaboration of The Canadian Public... read more
Vaccinated Canadians can have COVID-19 symptoms despite testing negative. Experts say people can test negative on a rapid test... read more
The National Advisory Committee on Immunization (NACI) has concluded that a precautionary approach of separating the time between administering... read more
Health experts have warned since omicron took over as the dominant strain that everyone is likely to get COVID-19... read more
Novavax has received approval for Canada’s first protein subunit COVID-19 vaccine called Nuvaxovid. Nuvaxovid (COVID-19 vaccine, recombinant protein, adjuvanted)... read more
Possible case of deer-to human Covid infection identified in Canada Researchers say its unlikely that the variant found in deer... read more
Image rights belong to: Ottawa City News (more…) read more